Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

11

Number of overlapping holdings

27.5%

% of HRTS's 41 holdings also in MEDI

33.3%

% of MEDI's 36 holdings also in HRTS

Overlap by Weight
Sector Drift (HRTS minus MEDI)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in HRTS
Weight
in MEDI
Overlap
ELI LILLY & CO 10.9% 11.7% 10.9%
UNITEDHEALTH GROUP INC 5.6% 8.3% 5.6%
INSULET CORP 1.8% 2.1% 1.8%
ASCENDIS PHARMA A/S 1.8% 19.1% 1.8%
ALNYLAM PHARMACEUTICALS INC 1.9% 1.7% 1.7%

Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to MEDI
BRIDGEBIO PHARMA, INC. 4.3%
ABBOTT LABORATORIES 4.0%
ASTRAZENECA PLC 4.0%
NOVO NORDISK A/S-B 3.9%
ROCHE HOLDINGS LTD-SPONS ADR 3.9%
VERTEX PHARMACEUTICALS INC 3.6%
GILEAD SCIENCES INC 3.1%
NOVARTIS AG 3.1%
MEDTRONIC PLC 3.0%
THERMO FISHER SCIENTIFIC INC 2.8%
HRTS Underweight Relative to MEDI
ASCENDIS PHARMA A/S -17.4%
LEGEND BIOTECH CORPORATION SPONSORED -8.1%
VAXCYTE, INC. -3.8%
LANTHEUS HOLDINGS INC -3.5%
OPTION CARE HEALTH INC -2.9%
UNITEDHEALTH GROUP INC -2.7%
DEXCOM INC -2.5%
INTUITIVE SURGICAL INC -2.4%
ICON PLC -2.3%
GLAUKOS CORP -2.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY